epigallocatechin gallate has been researched along with warfarin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 4 (50.00) | 2.80 |
Authors | Studies |
---|---|
Murakami, A | 1 |
Chen, K; Chen, L; Feng, Y; Jiang, H; Liu, D; Luo, C; Shen, X; Wu, J | 1 |
Dunckley, T; Gokhale, V; Hulme, C; Medda, F; Smith, B | 1 |
Han, J; Li, D; Liu, G; Liu, M; Wang, B; Wang, Z; Yuan, L; Zhang, M | 1 |
Bouajila, J; Bouarab, L; Cottaz, A; Degraeve, P; Jbilou, F; Joly, C; Oulahal, N | 1 |
Kshirsagar, S; Morton, H; Reddy, AP; Reddy, PH; Sawant, N | 1 |
Alvir, RV; Hindle, A; Kshirsagar, S; Kumar, S; Pradeepkiran, JA; Ramasubramaniam, B; Reddy, AP; Reddy, PH; Vijayan, M | 1 |
Ge, JP; Gu, JP; He, J; Li, Y; Ma, K; Yin, YY | 1 |
2 review(s) available for epigallocatechin gallate and warfarin
Article | Year |
---|---|
Chemoprevention with phytochemicals targeting inducible nitric oxide synthase.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Benzyl Alcohols; Catechin; Chemoprevention; Coumarins; Curcumin; Flavones; Mice; Nitric Oxide Synthase Type II; Rats; Resveratrol; Sesquiterpenes; Stilbenes | 2009 |
Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?
Topics: Alzheimer Disease; Animals; Anthraquinones; Biomedical Research; Carbolines; Catechin; Chromosomes, Human, Pair 21; Coumarins; Down Syndrome; Drug Design; Dyrk Kinases; Humans; Mice; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; tau Proteins | 2012 |
6 other study(ies) available for epigallocatechin gallate and warfarin
Article | Year |
---|---|
A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.
Topics: Catechin; Coumarins; Fluorescent Dyes; NAD; Peptides; Resveratrol; Sirtuin 1; Spectrometry, Fluorescence; Stilbenes | 2009 |
Competitive binding of (-)-epigallocatechin-3-gallate and 5-fluorouracil to human serum albumin: A fluorescence and circular dichroism study.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Binding Sites; Binding, Competitive; Catechin; Circular Dichroism; Drug Synergism; Fluorouracil; Humans; Ibuprofen; Protein Structure, Secondary; Serum Albumin, Human; Spectrometry, Fluorescence; Thermodynamics; Warfarin | 2017 |
Staphylococcus aureus membrane-damaging activities of four phenolics.
Topics: Anti-Bacterial Agents; Catechin; Cell Membrane; Coumarins; Naphthoquinones; Parabens; Phenols; Staphylococcus aureus | 2021 |
Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease.
Topics: Alzheimer Disease; Animals; Catechin; Cell Line; Coumarins; DNA-Binding Proteins; High Mobility Group Proteins; Hippocampus; Mice; Mitochondria; Mitochondrial Dynamics; Mitophagy; Neurons; NF-E2-Related Factor 2; Nuclear Respiratory Factor 1; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Synapses; Synaptophysin; tau Proteins | 2021 |
A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Catechin; Coumarins; Humans; Mice; Mitochondrial Dynamics; RNA, Messenger | 2022 |
The combination of EGCG with warfarin reduces deep vein thrombosis in rabbits through modulating HIF-1α and VEGF via the PI3K/AKT and ERK1/2 signaling pathways.
Topics: Animals; Anticoagulants; Catechin; Eosine Yellowish-(YS); Fibrinogen; Hematoxylin; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Polyphenols; Proto-Oncogene Proteins c-akt; Rabbits; Rats; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tea; Thrombin; Vascular Endothelial Growth Factor A; Venous Thrombosis; Warfarin | 2022 |